Talecris Biotherapeutics
United States

  Home About Talecris US Our Products Our Services Media Center Careers  
Our Products
Gamunex®
Prolastin®
Koāte®-DVI
Hypermunes™
GamaSTAN™ S/D
Dosing
HyperHEP B™ S/D
Dosing
HyperRAB™ S/D
Dosing
HyperRHO™ S/D
Dosing
HyperTET™ S/D
Dosing
Ultrasafe® Needle Guard
Distributors
Plasbumin®/Plasmanate®
Thrombate III®

GamaSTAN™ S/D, Immune Globulin (Human) Dosing Recommendations


Talecris is aware that the GamaSTAN™ S/D, Immune Globulin (Human) 2 mL prefilled syringe does not address all dosing situations.

Please refer to Important Dosing and Administration Information (PDF)

For immediate assistance or questions regarding the dosage and administration of GamaSTAN™ S/D, Immune Globulin (Human) please call 919.412.1030.

GamaSTAN™ S/D 2 mL prefilled syringes have been distributed only in the United States.


Indication
Dosage
Post-exposure to hepatitis A
0.02 mL/kg
Hepatitis A - Travel < 3 months stay
0.02 mL/kg
Hepatitis A - Travel > 3 months or longer
0.06 mL/kg (repeat every 4-6 months)
Measles prevention
0.25 mL/kg
Immunoglobulin deficiency
0.66 mL/kg every 3-4 weeks*
*Some patients may require more frequent dosing.



Product Information
Product
NDC#
Description
Size
GamaSTAN™ S/D
13533-635-03
Single Dose Syringe
2 mL
GamaSTAN™ S/D
13533-635-04
Single Dose Vial
2 mL
GamaSTAN™ S/D
13533-635-12
Single Dose Vial
10 mL


For more information call Talecris Biotherapeutics Customer Service at 1-800-243-4153 or your local distributor.

For clinical or technical questions call Talecris Biotherapeutics Clinical Communications at 1-800-520-2807.

 

 

Print This Page
E-mail This Page
Prescribing Information
View GamaSTAN™ S/D Prescribing Information (PDF)
Learn More

Immunization Action Coalition
Find vaccine information for healthcare professionals.
Learn More

Vaccine Information
Find information for the public and health professionals
Learn More

Talecris Biotherapeutics
Contact Talecris    Glossary    Site Map
General Conditions of Use    Privacy Statement    California Compliance
© 2008 Talecris Biotherapeutics